bladder cancer among men who had worked in Dunlop’s Fort Dunlop Works at Speke, and it seemed probable that Nonox S might be the responsible agent. Dunlop were told of these findings and warned that they might have a grave problem of bladder cancer among their workforce. In 1949 Dunlop stopped using Nonox S and ICI (the second defendants) stopped making it and withdrew it from their sales list. It was not until 1966 that these workers were diagnosed as suffering from the disease. The following extracts are from the judgment of O’Connor J, beginning at p 315:

DOI link for bladder cancer among men who had worked in Dunlop’s Fort Dunlop Works at Speke, and it seemed probable that Nonox S might be the responsible agent. Dunlop were told of these findings and warned that they might have a grave problem of bladder cancer among their workforce. In 1949 Dunlop stopped using Nonox S and ICI (the second defendants) stopped making it and withdrew it from their sales list. It was not until 1966 that these workers were diagnosed as suffering from the disease. The following extracts are from the judgment of O’Connor J, beginning at p 315:

bladder cancer among men who had worked in Dunlop’s Fort Dunlop Works at Speke, and it seemed probable that Nonox S might be the responsible agent. Dunlop were told of these findings and warned that they might have a grave problem of bladder cancer among their workforce. In 1949 Dunlop stopped using Nonox S and ICI (the second defendants) stopped making it and withdrew it from their sales list. It was not until 1966 that these workers were diagnosed as suffering from the disease. The following extracts are from the judgment of O’Connor J, beginning at p 315: